* About Us
          * Portfolio
          * Leadership
          * News & Insights
          * Contact
                EN CH

      Building the Future of Health Sciences

        OrbiMed seeks to invest globally in world-class healthcare companies to help drive innovation, address unmet medical needs, and improve patient outcomes.

      Providing tailored financing solutions and global team resources to help build
      world-class healthcare companies.

      From biopharmaceuticals to medical devices, digital health, diagnostics, and healthcare services, OrbiMed is scouting the globe for innovations that will help ensure humanity lives healthier, longer, and more productive lives.

      We have been investing globally for over 25 years across the healthcare industry: from early-stage private companies to large multinational corporations. Our team of over 130 distinguished scientific, medical, investment, and other professionals manages approximately $17 billion across public and private company investments worldwide.

      How We Invest

      Meet Our Companies Driving Healthcare Innovation

            Messenger RNA targeting to create life-saving therapeutics

            ADARx is developing a proprietary RNA targeting platform, including oligonucleotides for inhibition, degradation, and editing, together with novel oligonucleotide delivery technologies.

            Learn More

            People with cancer can’t wait. Let’s go.

            SpringWorks applies a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer.

            Learn More

            Pushing targeted oncology drug discovery to new heights

            Treeline Biosciences is pursuing molecular targets in oncology that are validated but difficult to drug, leveraging its four pillars of drug discovery: mechanistic biology, medicinal chemistry, computational science, and structural biology and protein science.

            Learn More
        View All

      $ 17 B

      AUM

      500 +

      Portfolio
      Companies

      130 +

      Total
      Professionals

      12

      Global
      Locations

      130 +

      Venture-backed
      IPOs

      News & Insights

      View All

        Orbimed News

        OrbiMed Raises Over $4.3 Billion Across Private Investment Funds

        Read More link

        Portfolio News

        Tal Zaks Featured on Invest Like the Best with Patrick O'Shaughnessy

        Read More link

        Portfolio News

        Boston Scientific Announces Agreement to Acquire Bolt Medical, Inc.

        Read More link

        Orbimed News

        OrbiMed Raises Over $4.3 Billion Across Private Investment Funds

        Read More link

        Portfolio News

        Tal Zaks Featured on Invest Like the Best with Patrick O'Shaughnessy

        Read More link

        Portfolio News

        Boston Scientific Announces Agreement to Acquire Bolt Medical, Inc.

        Read More link
        EN CH

      © 2025 OrbiMed | Privacy Policy | Terms of Use

        Manage Cookie Consent
        We will collect and process your personal information when you visit our website or otherwise interact with us. Please see our Privacy Policy for more information. To the extent that China’s Personal Information Protection Law is applicable, you may contact us via PrivacyPolicy@OrbiMed.com to obtain additional details about our processing of your information or exercise your rights.

        By clicking the button below, you agree to our processing of your personal information in accordance with the Privacy Policy, including sharing your personal information and transferring your personal information outside of China. If you do not agree, please do not use this website or provide your personal information to us.
        Functional Functional Always active
          The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
        Preferences Preferences
          The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
        Statistics Statistics
          The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
        Marketing Marketing
          The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
      Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
      Accept Deny View preferences Save preferences View preferences
      {title} {title} {title}
  Manage consent
    * English
    * Chinese